124.88
Overview
News
Price History
Option Chain
Financials
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $124.88, with a volume of 3.43M.
It is down -3.12% in the last 24 hours and down -15.62% over the past month.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$128.90
Open:
$129
24h Volume:
3.43M
Relative Volume:
1.72
Market Cap:
$35.32B
Revenue:
$6.95B
Net Income/Loss:
$1.30B
P/E Ratio:
27.33
EPS:
4.5696
Net Cash Flow:
$1.15B
1W Performance:
-3.67%
1M Performance:
-15.62%
6M Performance:
+6.44%
1Y Performance:
-9.56%
Agilent Technologies Inc Stock (A) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
(408) 345-8886
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
A
Agilent Technologies Inc
|
124.88 | 36.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
TMO
Thermo Fisher Scientific Inc
|
509.82 | 198.06B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
214.94 | 155.50B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
617.20 | 51.80B | 4.30B | 1.06B | 1.04B | 13.08 |
|
WAT
Waters Corp
|
319.83 | 32.29B | 3.17B | 642.63M | 539.81M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Initiated | HSBC Securities | Buy |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-15-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Oct-08-25 | Upgrade | UBS | Neutral → Buy |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-17-23 | Downgrade | UBS | Buy → Neutral |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| May-24-23 | Reiterated | Barclays | Equal Weight |
| May-24-23 | Reiterated | BofA Securities | Buy |
| May-24-23 | Reiterated | Citigroup | Neutral |
| May-24-23 | Reiterated | Credit Suisse | Outperform |
| May-24-23 | Reiterated | Evercore ISI | Outperform |
| May-24-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-24-23 | Reiterated | Robert W. Baird | Outperform |
| May-24-23 | Reiterated | SVB Securities | Outperform |
| May-24-23 | Reiterated | Stifel | Hold |
| May-24-23 | Reiterated | TD Cowen | Outperform |
| May-24-23 | Reiterated | Wells Fargo | Overweight |
| May-11-23 | Initiated | Barclays | Equal Weight |
| Jan-10-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jul-08-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-22 | Reiterated | BofA Securities | Buy |
| Feb-23-22 | Reiterated | Citigroup | Buy |
| Feb-23-22 | Reiterated | Cowen | Outperform |
| Feb-23-22 | Reiterated | Evercore ISI | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-23-22 | Reiterated | Wells Fargo | Overweight |
| Nov-23-21 | Reiterated | BofA Securities | Buy |
| Nov-23-21 | Reiterated | Cowen | Outperform |
| Nov-23-21 | Reiterated | Stifel | Hold |
| Mar-18-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Upgrade | UBS | Neutral → Buy |
| Nov-17-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-30-20 | Initiated | Atlantic Equities | Neutral |
| Aug-19-20 | Reiterated | BofA Securities | Neutral |
| Aug-19-20 | Reiterated | Citigroup | Neutral |
| Aug-19-20 | Reiterated | Jefferies | Buy |
| Aug-19-20 | Reiterated | Robert W. Baird | Outperform |
| Aug-19-20 | Reiterated | SVB Leerink | Outperform |
| Aug-19-20 | Reiterated | Stifel | Hold |
| Aug-19-20 | Reiterated | Wells Fargo | Overweight |
| Feb-24-20 | Downgrade | Needham | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-26-19 | Reiterated | Needham | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | UBS | Buy → Neutral |
| Jul-16-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-15-19 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Agilent Technologies Inc Stock (A) Latest News
Agilent Technologies, Inc. (NYSE:A) to Issue $0.26 Quarterly Dividend - MarketBeat
Agilent (A) Secures FDA Approval for Key Cancer Diagnostic Tool - GuruFocus
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC) - Yahoo Finance
Agilent Announces Cash Dividend of 25.5 Cents per Share - 01net
Agilent presents Boehringer Ingelheim with inaugural 2025 instrument Trade-in Impact Award - marketscreener.com
Agilent Slumps After Awarding Boehringer - Baystreet.ca
Agilent's Ovarian Cancer Diagnostic Test Receives FDA Clearance - marketscreener.com
FDA Approval Boosts Agilent Technologies (A) Diagnostic Tool - GuruFocus
Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - Bluefield Daily Telegraph
Madison Asset Management LLC Sells 14,089 Shares of Agilent Technologies, Inc. $A - MarketBeat
Gas Chromatography Detector Market Is Going to Boom |• Agilent Technologies • Thermo Fisher Scientific - openPR.com
Agilent Technologies, Inc. $A Position Cut by Impax Asset Management Group plc - MarketBeat
Agilent Unveils the 8850 Gas Chromatograph: A Leap Forward in Analytical Excellence - Quantisnow
Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A) - Yahoo Finance
Candriam S.C.A. Increases Holdings in Agilent Technologies, Inc. $A - MarketBeat
Envestnet Asset Management Inc. Raises Holdings in Agilent Technologies, Inc. $A - MarketBeat
Federated Hermes Inc. Has $273,000 Stock Position in Agilent Technologies, Inc. $A - MarketBeat
AGILENT TECHNOLOGIES, INC. ($A) CEO 2025 Pay Revealed - Quiver Quantitative
AAgilent Technologies Inc Stock Price and Quote - Finviz
What's Driving the Market Sentiment Around Agilent Technologies Inc? - Benzinga
Form DEFA14A AGILENT TECHNOLOGIES, - StreetInsider
Linscomb Wealth Inc. Invests $2.94 Million in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies (A) Valuation Check After New Automation And AI Lab Tools Showcase - Sahm
Agilent Showcases Next‑Generation Automated Solutions at SLAS2026 - BioSpace
Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet? - Yahoo Finance
Agilent Ekes up Ahead of Next Week’s Boston Fair - Baystreet.ca
Agilent Technologies Inc. Showcases Next-Generation Automated Solutions at SLAS2026 - marketscreener.com
Allianz Asset Management GmbH Has $96.71 Million Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25 - BioSpace
Agilent Technologies : and Virscidian Announce Collaboration to Streamline Access to OpenLab CDS Data in Analytical Studio - marketscreener.com
How is Agilent Technologies' stock performance compared to other healthcare stocks? - MSN
Mediolanum International Funds Ltd Sells 15,620 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. (A) Stock Analysis: Potential 26.76% Upside Raises Investor Optimism - DirectorsTalk Interviews
Agilent Technologies price tries to recoup some lossesForecast today02-02-2026 - Economies.com
National Pension Service Acquires 11,841 Shares of Agilent Technologies, Inc. $A - MarketBeat
AE Wealth Management LLC Has $9.54 Million Holdings in Agilent Technologies, Inc. $A - MarketBeat
Chromatograph (Labor): Why Agilent’s Lab Chromatography Systems Are Quietly Powering the Most Impo - AD HOC NEWS
Is Now The Time To Look At Buying Agilent Technologies, Inc. (NYSE:A)? - Yahoo Finance
Mutual of America Capital Management LLC Sells 12,121 Shares of Agilent Technologies, Inc. $A - MarketBeat
Chromatography Research Report 2026 - GlobeNewswire Inc.
Automated Sample Preparation Research Report 2026 - GlobeNewswire Inc.
Bank of New York Mellon Corp Trims Stake in Agilent Technologies, Inc. $A - MarketBeat
Published on: 2026-01-30 09:44:59 - baoquankhu1.vn
EPS Watch: Whats the beta of Agilent Technologies Inc stock2025 Price Targets & Scalable Portfolio Growth Methods - baoquankhu1.vn
Published on: 2026-01-29 09:46:24 - baoquankhu1.vn
North America Gas Chromatography Market Forecast Report 2025-2033 Featuring Agilent, Bio-Rad, Chromatotec, Merck, PerkinElmer, Phenomenex, Restek, Shimadzu, Thermo Fisher Scientific, Waters - Yahoo Finance
Published on: 2026-01-28 11:41:14 - baoquankhu1.vn
ETF Watch: Is Agilent Technologies Inc impacted by rising rates2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn
Microarrays Market Size to Accumulate Around USD 10.72 Billion by 2033, Driven by Expanding Genomics Research and Advanced Diagnostic Adoption – SNS Insider - GlobeNewswire Inc.
Agilent Technologies, Inc. (A) Stock Analysis: A Compelling 25.63% Potential Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
Agilent Technologies, Inc. $A Shares Sold by Teacher Retirement System of Texas - MarketBeat
Agilent Technologies Inc Stock (A) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):